Skip to main content
. 2020 Jun;97(6):402–408. doi: 10.1124/mol.119.118745

Fig. 1.

Fig. 1.

(A) Expression of GRP78 in different MDR and parental cancer cell lines. (B) CXL146 treatment resulted in a dose-dependent reduction of GRP78 in all cell lines tested with lower concentrations of CXL146 in MDR cell lines relative to the corresponding parental cell lines. These images are representative of at least three independent replicates.